On April 12, 2023 Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, reported its participation in the following upcoming virtual investor conferences (Press release, Cogent Biosciences, APR 12, 2023, View Source [SID1234629989]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

22nd Annual Needham Healthcare Conference
Wednesday, April 19, 2023 at 2:15 p.m. ET

Stifel 2023 Targeted Oncology Days
Tuesday, April 25, 2023 at 12:30 p.m. ET

A live webcast of each event can be accessed on the Investors & Media page of Cogent’s website at View Source A replay of the webcasts will be available approximately two hours after the completion of the events and will be archived for up to 30 days.